Published in Eur J Surg Oncol on August 05, 2008
Proton Therapy for Lymph Nodes in Breast Cancer (BR01) | NCT01365845
Sentinel lymph node biopsy of the internal mammary chain in breast cancer. Breast Cancer Res Treat (2012) 1.10
The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis. World J Surg (2012) 1.04
Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer. Cancer (2012) 0.93
Internal Mammary Sentinel Lymph Node Biopsy With Modified Injection Technique: High Visualization Rate and Accurate Staging. Medicine (Baltimore) (2015) 0.88
Role of FDG PET-CT in evaluation of locoregional nodal disease for initial staging of breast cancer. World J Clin Oncol (2014) 0.87
Recent advances in the surgical care of breast cancer patients. World J Surg Oncol (2010) 0.86
Meta-analysis of incidence of early lung toxicity in 3-dimensional conformal irradiation of breast carcinomas. Radiat Oncol (2013) 0.83
Validation study of the modified injection technique for internal mammary sentinel lymph node biopsy in breast cancer. Onco Targets Ther (2015) 0.81
Comparison of two treatment strategies for irradiation of regional lymph nodes in patients with breast cancer: Lymph flow guided portals versus standard radiation fields. Rep Pract Oncol Radiother (2014) 0.80
Axillary staging in breast cancer patients with exclusive lymphoscintigraphic drainage to the internal mammary chain. World J Surg (2011) 0.79
Validation study for the hypothesis of internal mammary sentinel lymph node lymphatic drainage in breast cancer. Oncotarget (2016) 0.77
Does the TNM classification of solitary internal mammary lymph node metastases in breast cancer still apply? Breast Cancer Res Treat (2016) 0.75
Prognostic Significance of Inner Quadrant Involvement in Breast Cancer Treated with Neoadjuvant Chemotherapy. J Breast Cancer (2016) 0.75
Why do we need irradiation of internal mammary lymph nodes in patients with breast cancer: Analysis of lymph flow and radiotherapy studies. Rep Pract Oncol Radiother (2016) 0.75
Extended lymph-node dissection for gastric cancer. N Engl J Med (1999) 7.43
Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol (2004) 6.47
Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst (2000) 4.15
Systematic review of enhanced recovery programmes in colonic surgery. Br J Surg (2006) 3.55
Glutamine and the preservation of gut integrity. Lancet (1993) 2.72
Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet (2001) 2.64
Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer (2008) 2.62
[Dutch Institute for Healthcare Improvement guideline, "Treatment of breast cancer"]. Ned Tijdschr Geneeskd (2002) 2.39
A protocol is not enough to implement an enhanced recovery programme for colorectal resection. Br J Surg (2007) 2.11
Effect of adjuvant chemotherapy in postmenopausal patients with invasive ductal versus lobular breast cancer. Ann Oncol (2012) 2.06
On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands. Cancer Causes Control (2007) 1.93
Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer (2005) 1.93
Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol (2003) 1.69
Implementation of a short-stay programme after breast cancer surgery. Br J Surg (2010) 1.54
Sustainability of an enhanced recovery after surgery program (ERAS) in colonic surgery. World J Surg (2015) 1.53
The introduction of mammographical screening has had little effect on the trend in breast-conserving surgery: a population-based study in Southeast Netherlands. Eur J Cancer (2001) 1.53
[Trends and variation in breast conserving surgery in the southeast and east of the Netherlands over the period 1990-2002]. Ned Tijdschr Geneeskd (2005) 1.50
Measurement of resting energy expenditure in a clinical setting. Clin Nutr (1990) 1.48
Using loco-regional recurrence as an indicator of the quality of breast cancer treatment. Eur J Cancer (2004) 1.48
[Nutrition and cancer: causative, protective and therapeutic aspects]. Ned Tijdschr Geneeskd (1999) 1.40
Presence of symptoms and timing of surgery do not affect the prognosis of patients with primary metastatic breast cancer. Eur J Surg Oncol (2011) 1.40
Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer (2001) 1.19
Length of stay: an inappropriate readout of the success of enhanced recovery programs. World J Surg (2008) 1.19
Economic evaluation of four follow-up strategies after curative treatment for breast cancer: results of an RCT. Eur J Cancer (2011) 1.18
Clinical epidemiology of breast cancer in the elderly. Eur J Cancer (2007) 1.17
A comparison of quality of life, disease impact and risk perception in women with invasive breast cancer and ductal carcinoma in situ. Eur J Cancer (2006) 1.17
Socioeconomic inequalities in attending the mass screening for breast cancer in the south of the Netherlands--associations with stage at diagnosis and survival. Breast Cancer Res Treat (2011) 1.16
Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Eur J Surg Oncol (2009) 1.12
Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer (2005) 1.10
Breast cancer in the southeastern Netherlands, 1960-1989: trends in incidence and mortality. Eur J Cancer (1993) 1.09
Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study. Eur J Cancer (2006) 1.09
Age-specific differences in treatment and survival of patients with cervical cancer in the southeast of The Netherlands, 1986-1996. Eur J Cancer (2002) 1.06
Adherence to treatment guidelines and survival in patients with early-stage breast cancer by age at diagnosis. Br J Surg (2012) 1.06
Improved survival of patients with rectal cancer since 1980: a population-based study. Eur J Cancer (2003) 1.04
Plasma-amino acid profiles in sepsis and stress. Ann Surg (1989) 1.03
The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma. Eur J Surg Oncol (2005) 1.02
Personality predicts quality of life six months after the diagnosis and treatment of breast disease. Ann Surg Oncol (2006) 1.02
Long-term follow-up after open cholecystectomy. Br J Surg (1993) 1.00
Preoperative assessment of local tumor extent in advanced rectal cancer: CT or high-resolution MRI? Abdom Imaging (2000) 1.00
The prognostic significance of axillary lymph-node micrometastases in breast cancer patients. Eur J Surg Oncol (2005) 0.99
Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer. Breast Cancer Res Treat (2006) 0.99
Gut permeability, intestinal morphology, and nutritional depletion. Nutrition (1998) 0.99
Impact of transition from analog screening mammography to digital screening mammography on screening outcome in The Netherlands: a population-based study. Ann Oncol (2012) 0.99
The role of ultrasound-guided lymph node biopsy in axillary staging of invasive breast cancer in the post-ACOSOG Z0011 trial era. Ann Surg Oncol (2014) 0.99
Local recurrence following breast-conserving treatment in women aged 40 years or younger: trends in risk and the impact on prognosis in a population-based cohort of 1143 patients. Eur J Cancer (2013) 0.98
Glutamine appearance rate in plasma is not increased after gastrointestinal surgery in humans. J Nutr (2000) 0.98
Radical resection of locally advanced colorectal cancer. Br J Surg (1995) 0.97
Estimation of body composition by bioelectrical impedance in cancer patients. Eur J Clin Nutr (1990) 0.97
Resting energy expenditure in patients with non-small cell lung cancer. Cancer (1991) 0.97
Increased health care utilisation among 10-year breast cancer survivors. Support Care Cancer (2006) 0.97
Screening caused rising incidence rates of ductal carcinoma in situ of the breast. Breast Cancer Res Treat (2008) 0.97
Nutritional depletion and dietary manipulation: effects on the immune response. World J Surg (1999) 0.96
Sentinel lymph node biopsy to direct treatment in gastric cancer. A systematic review of the literature. Eur J Surg Oncol (2011) 0.95
Improved survival of patients with primary distant metastatic breast cancer in the period of 1995-2008. A nationwide population-based study in the Netherlands. Breast Cancer Res Treat (2011) 0.94
Blood-brain barrier derangement in sepsis: cause of septic encephalopathy? Am J Surg (1981) 0.93
Nurse-led telephone follow-up and an educational group programme after breast cancer treatment: results of a 2 × 2 randomised controlled trial. Eur J Cancer (2011) 0.92
Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: a case-control study of histological factors and alterations in oncogene expression. Int J Radiat Oncol Biol Phys (1999) 0.91
Results of tailored treatment for breast cancer patients with internal mammary lymph node metastases. Breast (2009) 0.91
Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection. Eur J Surg Oncol (2006) 0.91
Recurrence and survival after abdominoperineal and low anterior resection for rectal cancer, without adjunctive therapy. Eur J Surg Oncol (1990) 0.90
Effect of different tumor types on resting energy expenditure. Cancer Res (1991) 0.90
Cancer cachexia and its nutritional implications. Br J Surg (1983) 0.88
Prognostic factors for survival in metastatic breast cancer by hormone receptor status. Breast Cancer Res Treat (2014) 0.88
Glutamine extraction by the gut is reduced in depleted [corrected] patients with gastrointestinal cancer. Ann Surg (1997) 0.87
Stage migration due to introduction of the sentinel node procedure: a population-based study. Breast Cancer Res Treat (2008) 0.86
Trends in surgery for screen-detected and interval breast cancers in a national screening programme. Br J Surg (2014) 0.85
The role of ultrasonography as an adjunct to mammography in the detection of breast cancer. a systematic review. Eur J Cancer (2002) 0.84
Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation. Radiother Oncol (1999) 0.84
Patterns in current anaesthesiological peri-operative practice for colonic resections: a survey in five northern-European countries. Acta Anaesthesiol Scand (2006) 0.84
Blood-brain barrier derangement in uremic encephalopathy. Surgery (1982) 0.84
Response of glutamine metabolism to glutamine-supplemented parenteral nutrition. Am J Clin Nutr (2000) 0.84
A systematic review of the relation between interleukin-2 schedule and outcome in patients with metastatic renal cell cancer. Eur J Cancer (2004) 0.84
Inferior survival for young patients with contralateral compared to unilateral breast cancer: a nationwide population-based study in the Netherlands. Breast Cancer Res Treat (2013) 0.83
Preoperative serum CA125 levels do not predict suboptimal cytoreductive surgery in epithelial ovarian cancer. Int J Gynecol Cancer (2007) 0.83
Explanatory factors for variation in the use of breast conserving surgery and radiotherapy in the Netherlands, 1990-2001. Breast (2007) 0.83
Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands. Breast Cancer Res Treat (2011) 0.83
Prevalence of lymphoedema more than five years after breast cancer treatment. Eur J Surg Oncol (2011) 0.83
Reliability of receptor assessment on core needle biopsy in breast cancer patients. Tumour Biol (2012) 0.82
Prognosis following local recurrence after breast conserving treatment in young women with early breast cancer. Eur J Surg Oncol (2013) 0.82
Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer. Br J Cancer (2012) 0.82
Follow-up after curative treatment for breast cancer: why do we still adhere to frequent outpatient clinic visits? Eur J Cancer (2007) 0.82
The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer. Br J Cancer (2003) 0.82
To eat or not to eat: facilitating early oral intake after elective colonic surgery in the Netherlands. Clin Nutr (2008) 0.82
[Breast cancer in young women: epidemiology and treatment dilemmas]. Ned Tijdschr Geneeskd (2008) 0.82
Patients with invasive lobular breast cancer are less likely to undergo breast-conserving surgery: a population based study in the Netherlands. Ann Surg Oncol (2014) 0.82
Glutamine: an essential amino acid for the gut. Nutrition (1997) 0.82
ARM: axillary reverse mapping - the need for selection of patients. Eur J Surg Oncol (2012) 0.81
Results of sentinel node biopsy not affected by previous excisional biopsy. Eur J Surg Oncol (2005) 0.81
Activated macrophages containing tumor marker in colon carcinoma: immunohistochemical proof of a concept. Tumour Biol (2011) 0.81
Glutamine depletion and increased gut permeability in nonanorectic, non-weight-losing tumor-bearing rats. Gastroenterology (1997) 0.80
Glutamine and intestinal immune cells in humans. JPEN J Parenter Enteral Nutr (1998) 0.80
Assessment of outcome of perioperative nutritional interventions. Nutrition (1998) 0.80
Preoperative total parenteral nutrition (TPN) in severe Crohn's disease. Surgery (1988) 0.80
DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients. Endocr Relat Cancer (2007) 0.80
Increased proliferative activity and p53 expression in normal glandular breast tissue after radiation therapy. J Pathol (1998) 0.80